HUT77933A - Funkcionális terpiridin-fémkomplexek, eljárás előállításukra valamint alkalmazásuk - Google Patents

Funkcionális terpiridin-fémkomplexek, eljárás előállításukra valamint alkalmazásuk

Info

Publication number
HUT77933A
HUT77933A HU9801807A HU9801807A HUT77933A HU T77933 A HUT77933 A HU T77933A HU 9801807 A HU9801807 A HU 9801807A HU 9801807 A HU9801807 A HU 9801807A HU T77933 A HUT77933 A HU T77933A
Authority
HU
Hungary
Prior art keywords
terpyridine
metal complexes
pct
preparation
terpyridine metal
Prior art date
Application number
HU9801807A
Other languages
English (en)
Other versions
HU217774B (hu
Inventor
Jonathan Hall
Dieter Hüsken
Robert Häner
Heinz Moser
Uwe Pieles
Original Assignee
Novartis Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag. filed Critical Novartis Ag.
Publication of HUT77933A publication Critical patent/HUT77933A/hu
Publication of HU217774B publication Critical patent/HU217774B/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6816Hybridisation assays characterised by the detection means
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2458/00Labels used in chemical analysis of biological material
    • G01N2458/40Rare earth chelates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
HU9801807A 1994-09-02 1995-08-30 Funkcionális terpiridin-fémkomplexek, eljárás előállításukra valamint alkalmazásuk HU217774B (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH269394 1994-09-02

Publications (2)

Publication Number Publication Date
HUT77933A true HUT77933A (hu) 1998-11-30
HU217774B HU217774B (hu) 2000-04-28

Family

ID=4239459

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9801807A HU217774B (hu) 1994-09-02 1995-08-30 Funkcionális terpiridin-fémkomplexek, eljárás előállításukra valamint alkalmazásuk

Country Status (15)

Country Link
US (1) US5925744A (hu)
EP (1) EP0778844B1 (hu)
JP (1) JPH10505354A (hu)
AT (1) ATE229969T1 (hu)
AU (1) AU695749B2 (hu)
CA (1) CA2197788A1 (hu)
CY (1) CY2435B1 (hu)
DE (1) DE59510515D1 (hu)
DK (1) DK0778844T3 (hu)
ES (1) ES2191060T3 (hu)
FI (1) FI970740A (hu)
HU (1) HU217774B (hu)
NO (1) NO316866B1 (hu)
PT (1) PT778844E (hu)
WO (1) WO1996007668A1 (hu)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU739391B2 (en) * 1996-07-03 2001-10-11 President And Fellows Of Harvard College Oligonucleotide linker and techniques involving immobilized and linked oligonucleotides
US6376664B1 (en) * 1999-03-17 2002-04-23 The Ohio State University Cyclic bis-benzimidazole ligands and metal complexes thereof
US6407089B1 (en) 1999-12-23 2002-06-18 Trinapco Inc. Triazatrinaphthyrins and the use thereof
EP1244665B1 (en) * 1999-12-23 2005-08-10 Trinapco, Inc Triazatrinaphthyrins and the use thereof
GB0007764D0 (en) * 2000-03-30 2000-05-17 Bp Chem Int Ltd Polymerisation catalyst
FR2810406B1 (fr) * 2000-06-15 2002-09-20 Cis Bio Int Nouveaux cryptates de terre rare peu sensibles a l'extinction de fluorescence
WO2007125173A2 (en) 2006-05-03 2007-11-08 Baltic Technology Development, Ltd. Antisense agents combining strongly bound base - modified oligonucleotide and artificial nuclease
ES2668555T3 (es) 2008-05-27 2018-05-18 Dako Denmark A/S Composiciones y métodos para la detección de aberraciones cromosómicas con tampones de hibridación novedosos
US9303287B2 (en) 2009-02-26 2016-04-05 Dako Denmark A/S Compositions and methods for RNA hybridization applications
US20110151457A1 (en) 2009-12-22 2011-06-23 Elitech Holding B.V. Hypertheromostable endonuclease iv substrate probe
EP2761028A1 (en) 2011-09-30 2014-08-06 Dako Denmark A/S Hybridization compositions and methods using formamide
EP2768974B1 (en) 2011-10-21 2017-07-19 Dako Denmark A/S Hybridization compositions and methods
CN114315702A (zh) * 2022-02-11 2022-04-12 南京邮电大学 一种基于低维镧系金属配合物X射线激发闪烁体Eu-TPC及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4806463A (en) * 1986-05-23 1989-02-21 Worcester Foundation For Experimental Biology Inhibition of HTLV-III by exogenous oligonucleotides
EP0266099A3 (en) * 1986-10-28 1990-09-19 The Johns Hopkins University Oligonucleoside alkyl or arylphosphonate derivatives capable of crosslinking with or cleaving nucleic acids
DE68925278T2 (de) * 1988-02-26 1996-09-19 Worcester Found Ex Biology Hemmung von htlv-iii durch exogene oligonukleotide
US5559207A (en) * 1989-03-06 1996-09-24 Board Of Regents, University Of Texas Texaphyrin metal complex mediated ester hydrolysis
US5760191A (en) * 1993-02-05 1998-06-02 Nycomed Imaging As Macrocyclic complexing agents and targeting immunoreagents useful in therapeutic and diagnostic compositions and methods

Also Published As

Publication number Publication date
DE59510515D1 (de) 2003-01-30
EP0778844A1 (de) 1997-06-18
FI970740A0 (fi) 1997-02-21
AU3474495A (en) 1996-03-27
NO316866B1 (no) 2004-06-07
JPH10505354A (ja) 1998-05-26
ATE229969T1 (de) 2003-01-15
FI970740A (fi) 1997-02-21
DK0778844T3 (da) 2003-03-31
NO970886D0 (no) 1997-02-27
ES2191060T3 (es) 2003-09-01
CA2197788A1 (en) 1996-03-14
NO970886L (no) 1997-04-25
PT778844E (pt) 2003-04-30
AU695749B2 (en) 1998-08-20
WO1996007668A1 (de) 1996-03-14
US5925744A (en) 1999-07-20
HU217774B (hu) 2000-04-28
EP0778844B1 (de) 2002-12-18
CY2435B1 (en) 2004-11-12

Similar Documents

Publication Publication Date Title
HUT77933A (hu) Funkcionális terpiridin-fémkomplexek, eljárás előállításukra valamint alkalmazásuk
HK1152246A1 (en) Compositions for treating cancer
GR3032355T3 (en) Cyclodextrin cellular delivery system for oligonucleotides
EP1108724A3 (en) Synthesis of methoxy nucleosides and enzymatic nucleic acid molecules
MX9605716A (es) Metodos y composiciones para el tratamiento de restenosis y cancer usando ribozimas.
EP0635001A1 (en) SUBSTITUTED THIOURANTS AS BIFUNCTIONAL CHELATORS.
PL350567A1 (en) Process for producing nitrosonium ions
UA85993C2 (ru) Конъюгат, который содержит бактериальный суперантиген и антительную составную, фармацевтическая композиция, которая его содержит, и способ лечения рака у млекопитающего
HK1023064A1 (en) Method of inhibiting bacterial or fungal growth using a complexing agent
MY103365A (en) 4-demethoxy-4-amino-anthracyclines
SI1075477T1 (en) Novel Benzonaphthyridine-N-oxides
GB9200607D0 (en) Pharmaceutical compositions containing nifedipine and process for the preparation thereof
IL151289A0 (en) Method for preparing functionalised polyalkylenimines, composition containing same and uses thereof
HU911928D0 (en) Process for the production of chelates and its complexes containing orto ligating functional group, and the medical preparations containing thereof
Ohnishi et al. Oxidative DNA Damage Induced by a Metabolite of 2–Naphthylamine, a Smoking‐related Bladder Carcinogen
NZ504291A (en) Compositions and methods for targeted delivery of factors
Suzuki et al. Nucleotide sequence cleavages of manganese-bleomycin induced by reductant, hydrogen peroxide and ultraviolet light. Comparison with iron-and cobalt-bleomycins
BG104034A (en) Method for the preparation of pharmaceutical compounds of antidepressive effect and against the parkinson syndrome effect
MX9709471A (es) Complejos metalicos multidentados y metodos para preparar y usar los mismos.
ZA200005110B (en) Process for preparing intermediates.
EP0369398A3 (en) Polyphosphazene derivatives containing carbonyl groups suitable for photoreticulation processes
AP2000001835A0 (en) Agents.
ATE273027T1 (de) Zusammensetzung zur behandlung von entzündungen
MX9710501A (es) Metodo de purificacion por extraccion a partir de un medio liquido.
Sun et al. Effect of Nifedipine on Proliferation and DNA Synthesis of Human Gingival Fibroblasts

Legal Events

Date Code Title Description
MM4A Lapse of definitive patent protection due to non-payment of fees